Gary Richardson

机构：Cabrini Hospital · ORCID：0000-0003-2122-8285

发表论文 190 篇 · 总被引 7586 次 · h-index 30

代表论文

• D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial (2025 · Nature Medicine · 被引 21)
• Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• First-in-human mRNA CAR therapy: Correlative biomarker analysis from the MT-302 phase 1 study targeting TROP2 in patients with advanced epithelial tumors. (2025 · Journal of Clinical Oncology · 被引 13)
• Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer Registry (2025 · Clinical Oncology · 被引 9)
• Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial (2025 · Journal of Clinical Oncology · 被引 7)
• Breast cancer organoids: Advancements and applications in precision medicine (2025 · Critical Reviews in Oncology/Hematology · 被引 6)